Related Experiment Videos

Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy

K A al-Shoumer1, K H Cox, C L Hughes

  • 1Unit of Metabolic Medicine, Imperial College School of Medicine, St. Mary's Hospital, London, United Kingdom.

Insights

Hypopituitarism is linked to unhealthy lipid profiles, especially in women, increasing vascular disease risk. Standard hormone replacement therapy does not fully correct these dangerous lipid and lipoprotein changes.

Area of Science:

  • Endocrinology
  • Cardiovascular Disease Research
  • Metabolic Disorders

Background:

  • Hypopituitary patients exhibit increased mortality, primarily from vascular disease.
  • Lipid and lipoprotein metabolism is crucial for cardiovascular health.

Purpose of the Study:

  • To investigate circulating lipid and lipoprotein concentrations in hypopituitary women and men compared to controls.
  • To assess the impact of conventional hormone replacement therapy on lipid profiles.

Main Methods:

  • Two studies were conducted: a cross-sectional overnight fast study and a 24-hour ambulatory monitoring study.
  • Measurements included triglycerides, total cholesterol, HDL cholesterol, LDL cholesterol, apolipoprotein B, apolipoprotein A1, and lipoprotein(a).

Main Results:

  • Hypopituitary women showed elevated fasting triglycerides, total cholesterol, LDL cholesterol, and apolipoprotein B compared to controls.
  • Postprandial and 24-hour measurements revealed significantly higher triglyceride and total cholesterol levels in hypopituitary women.
  • While less pronounced, hypopituitary men also had a higher proportion with elevated total and LDL cholesterol.

Conclusions:

  • Hypopituitarism, even with standard hormone replacement, is associated with adverse lipid and lipoprotein profiles, particularly in women.
  • These lipid alterations may contribute to the increased vascular morbidity and mortality observed in hypopituitary patients.

Related Concept Videos